These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1933851)

  • 1. In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using 19F nuclear magnetic resonance spectroscopy.
    el-Tahtawy A; Wolf W
    Cancer Res; 1991 Nov; 51(21):5806-12. PubMed ID: 1933851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopy.
    Katzir I; Shani J; Wolf W; Chatterjee-Parti S; Berman E
    Cancer Invest; 2000; 18(1):20-7. PubMed ID: 10701363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy.
    Guerquin-Kern JL; Leteurtre F; Croisy A; Lhoste JM
    Cancer Res; 1991 Oct; 51(20):5770-3. PubMed ID: 1913695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells.
    Keniry M; Benz C; Shafer RH; James TL
    Cancer Res; 1986 Apr; 46(4 Pt 1):1754-8. PubMed ID: 3456267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of 5-ethynyluracil on 5-fluorouracil metabolism determined by 19F nuclear magnetic resonance spectroscopy.
    Adams ER; Leffert JJ; Craig DJ; Spector T; Pizzorno G
    Cancer Res; 1999 Jan; 59(1):122-7. PubMed ID: 9892196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.
    Aboagye EO; Artemov D; Senter PD; Bhujwalla ZM
    Cancer Res; 1998 Sep; 58(18):4075-8. PubMed ID: 9751613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.
    McSheehy PM; Prior MJ; Griffiths JR
    Br J Cancer; 1992 Mar; 65(3):369-75. PubMed ID: 1558790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
    Malet-Martino M; Gilard V; Desmoulin F; Martino R
    Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours.
    McSheehy PM; Port RE; Rodrigues LM; Robinson SP; Stubbs M; van der Borns K; Peters GJ; Judson IR; Leach MO; Griffiths JR
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):117-28. PubMed ID: 15592719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.
    Presant CA; Wolf W; Albright MJ; Servis KL; Ring R; Atkinson D; Ong RL; Wiseman C; King M; Blayney D
    J Clin Oncol; 1990 Nov; 8(11):1868-73. PubMed ID: 2230874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New techniques in the pharmacokinetic analysis of cancer drugs. III. Nuclear magnetic resonance.
    Maxwell RJ
    Cancer Surv; 1993; 17():415-23. PubMed ID: 8137351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate increases the activation and cytotoxicity of 5-fluorouracil: detected by 19F n.m.r. in vivo.
    McSheehy PM; Prior MJ; Griffiths JR
    Biochem Soc Trans; 1989 Dec; 17(6):1050. PubMed ID: 2628073
    [No Abstract]   [Full Text] [Related]  

  • 17. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver.
    Sijens PE; Huang YM; Baldwin NJ; Ng TC
    Cancer Res; 1991 Mar; 51(5):1384-90. PubMed ID: 1997177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
    Aboagye EO; Maxwell RJ; Kelson AB; Tracy M; Lewis AD; Graham MA; Horsman MR; Griffiths JR; Workman P
    Cancer Res; 1997 Aug; 57(15):3314-8. PubMed ID: 9242466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
    de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
    Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.